Habico Invest
ActiveVenture Capital
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Habico Invest.
Key people at Habico Invest.
# Habico Invest: A Danish Family Office Navigating Diversified Wealth Creation
Habico Invest stands as a distinguished Danish family office established by Birgitte and Hans Bøgh-Sørensen, the founders of the prominent Orifarm Group.[1][2] The firm operates as a single-family office headquartered in Odense, Denmark, managing the Bøgh-Sørensen family's substantial wealth through a deliberately diversified investment approach.[3] Rather than concentrating capital in a single asset class, Habico Invest deploys capital across private equity, venture capital, real estate, wine, and alternative investments—a strategy designed to preserve and grow family wealth while maintaining exposure to multiple market dynamics. The firm's investment philosophy centers on long-term value creation and strategic diversification, with a disciplined approach to portfolio management that emphasizes prudent stewardship across both public and private markets.[2]
Habico Invest emerged from the entrepreneurial success of Birgitte and Hans Bøgh-Sørensen, whose founding of Orifarm Group—a significant player in the pharmaceutical and healthcare sectors—generated the capital base that would become the foundation for the family office.[1][2] The establishment of Habico Invest represented a natural evolution for the family, transitioning from operating a single successful enterprise to managing a diversified portfolio of investments. This transition reflects a common pattern among European family offices: successful founders leverage their operational expertise and capital to build multi-generational wealth vehicles. The family's background in healthcare and pharmaceuticals has clearly influenced their investment thesis, with these sectors remaining prominent in their allocation strategy.
Unlike venture-focused firms that concentrate on early-stage technology companies, Habico Invest operates across a spectrum of investment stages and asset classes. The firm invests from seed through late-stage and buyout opportunities, allocating capital to private equity, venture capital, real estate, wine, and collectible cars.[2] This diversification provides natural hedging against sector-specific downturns and allows the family office to capitalize on opportunities across different market cycles.
The firm maintains focused expertise in technology, healthcare, consumer goods, pharmaceuticals, and manufacturing—sectors where the founding family possesses deep operational knowledge.[2] Geographically, Habico Invest targets investments across the United States, United Kingdom, Germany, Denmark, and Czech Republic, providing exposure to both mature and emerging European markets while maintaining significant North American presence.[2]
The fund managers bring extensive venture capital experience, having executed over 50 deals with a particular emphasis on early to growth-stage companies in technology and healthcare.[1] This operator-first approach fosters deep collaboration with portfolio companies, driving innovation and sustainable growth rather than pursuing purely financial engineering strategies. The firm's data-driven methodology enables systematic identification of high-potential startups with strong exit potential.
With typical investment sizes ranging from $1 million to $50 million USD, Habico Invest possesses the capital flexibility to participate meaningfully in both early-stage venture rounds and larger growth equity or buyout transactions.[2] This sizing capability allows the firm to serve as a lead investor in smaller opportunities while also participating as a co-investor in larger institutional rounds.
Habico Invest occupies a distinctive position within European venture and private markets infrastructure. As a family office with substantial capital and operational expertise, the firm represents the professionalization of family wealth management in Northern Europe—a trend accelerating as successful entrepreneurs seek to deploy capital beyond their founding companies. The firm's emphasis on healthcare and technology aligns with broader European investment trends, where these sectors have attracted increasing institutional capital following years of underinvestment relative to North America.
The family office model itself has become increasingly important to startup ecosystems, particularly in Europe. Unlike traditional venture funds constrained by limited partnership agreements and fund lifecycles, family offices like Habico Invest can take longer-term views on investments, provide patient capital during downturns, and maintain positions through multiple market cycles. This structural advantage has made family offices increasingly influential in shaping which companies receive follow-on funding and strategic support.
Habico Invest's geographic focus—particularly its presence in Denmark and Central Europe—reflects the growing maturation of venture ecosystems outside traditional hubs. The firm's willingness to invest across the United Kingdom, Germany, and Czech Republic demonstrates confidence in regional innovation ecosystems and contributes to capital distribution beyond London and Berlin's dominant positions.
Habico Invest exemplifies the evolution of European family offices from passive wealth preservation vehicles into active participants in venture and growth equity markets. The firm's combination of operational expertise, diversified capital base, and disciplined investment approach positions it well to navigate the increasingly complex landscape of private markets.
Looking forward, several dynamics will likely shape Habico Invest's trajectory. First, the consolidation of European venture capital will create both opportunities and challenges—larger institutional competitors may crowd certain segments, but the family office's flexibility and patient capital will remain valuable in supporting founders through extended fundraising cycles. Second, the healthcare and pharmaceutical sectors will continue attracting significant capital as aging populations and digital health innovation create sustained tailwinds. Third, the firm's diversified approach across asset classes provides natural optionality as macroeconomic conditions shift—real estate and alternative investments can provide stability during venture downturns.
The family office model itself faces evolution pressures. Regulatory scrutiny around fund structures, pressure to demonstrate ESG credentials, and competition for deal flow from mega-funds will test whether smaller family offices can maintain their edge. Habico Invest's established track record, sector expertise, and geographic positioning suggest the firm is well-positioned to thrive in this environment, though continued success will depend on maintaining investment discipline and adapting to shifting market dynamics. The firm's influence on the broader ecosystem will likely grow as European venture capital matures and family offices increasingly serve as anchors for regional investment communities.
Key people at Habico Invest.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 1, 2024 | Crescenta | $7.0M Series A | — | All Iron Ventures, Brighteye Ventures, FJ Labs, KFund, Round2 Capital Partners, Simon Rogerson, Victor Pancic, CFA, Yago Arbeloa |
| Jun 1, 2023 | Crescenta | $4.0M Seed | — | All Iron Ventures, Brighteye Ventures, FJ Labs, KFund, Round2 Capital Partners, François Nuyts, Hugo Arevalo, Simon Rogerson, Victor Pancic, CFA, Yago Arbeloa |
| May 1, 2023 | Oneday | $6.0M Series A | — | Ananda Impact Ventures, Brighteye Ventures, Concept Ventures, Jenny Fielding, Scott Hartley, FJ Labs, Playfair Capital, Round2 Capital Partners, Simon Rogerson, Victor Pancic, CFA |
| Apr 1, 2022 | Oneday | $3.0M Seed | — | Brighteye Ventures, FJ Labs, Round2 Capital Partners, Simon Rogerson, Victor Pancic, CFA |
| May 1, 2020 | Envelop Risk | $6.0M Series A | — | — |
